TY  - JOUR

T1  - 105: Growth Analysis at Baseline in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis Enrolled in Phase 3 Dupilumab Trials

JO  - Journal of Investigative Dermatology

UR  - https://doi.org/10.1016/j.jid.2025.02.110

PY  - 2025/03/01

AU  - Irvine AD

AU  - Paller AS

AU  - Siegfried EC

AU  - Cork MJ

AU  - Beck LA

AU  - Chen Z

AU  - Peralta C

AU  - Zhang A

AU  - Levy S

AU  - Cyr SL

ED  - 

DO  - DOI: 10.1016/j.jid.2025.02.110

PB  - Elsevier BV

VL  - 145

IS  - 3

SP  - e26

EP  - e26

Y2  - 2025/04/05

ER  -